Search research articles
Contact Us
Filters
Showing results (51-60 of 160) with videos related to
Page
of 16
Sort By:
European Journal of Drug Metabolism and Pharmacokinetics
|
April 5, 2018
Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
Peter Matzneller, Manuel Kussmann, Sabine Eberl, et al.
Nuclear Medicine and Biology
|
July 13, 2013
(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP
Kerstin Römermann, Thomas Wanek, Marion Bankstahl, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 1, 2023
Effect of budesonide on pulmonary activity of multidrug resistance-associated protein 1 assessed with PET imaging in rats
Severin Mairinger, Irene Hernández-Lozano, Lena Zachhuber, et al.
The AAPS Journal
|
May 1, 2019
Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
Irene Hernández Lozano, Rudolf Karch, Martin Bauer, et al.
Pharmaceutics
|
August 28, 2021
Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice
Irene Hernández-Lozano, Severin Mairinger, Alexander Traxl, et al.
European Journal of Clinical Pharmacology
|
August 6, 2009
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer, Rudolf Karch, Friederike Neumann, et al.
Theranostics
|
January 8, 2019
PET-MR and SPECT-MR multimodality probes: Development and challenges
Chang-Tong Yang, Krishna K Ghosh, Parasuraman Padmanabhan, et al.
Journal of Pharmaceutical Sciences
|
February 9, 2016
Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice
Thomas Wanek, Emina Halilbasic, Michele Visentin, et al.
British Journal of Clinical Pharmacology
|
April 13, 2017
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[<sup>11</sup> C]verapamil in elderly vs. young subjects
Martin Bauer, Beatrix Wulkersdorfer, Rudolf Karch, et al.
Molecular Pharmacology
|
June 14, 2019
Generation and Characterization of an <i>Abcc1</i> Humanized Mouse Model (<i>hABCC1<sup>flx/flx</sup></i> ) with Knockout Capability
Markus Krohn, Viktoria Zoufal, Severin Mairinger, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 160) with videos related to
Sort By:
Page
of 16
European Journal of Drug Metabolism and Pharmacokinetics
|
April 5, 2018
Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
Peter Matzneller, Manuel Kussmann, Sabine Eberl, et al.
Nuclear Medicine and Biology
|
July 13, 2013
(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP
Kerstin Römermann, Thomas Wanek, Marion Bankstahl, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 1, 2023
Effect of budesonide on pulmonary activity of multidrug resistance-associated protein 1 assessed with PET imaging in rats
Severin Mairinger, Irene Hernández-Lozano, Lena Zachhuber, et al.
The AAPS Journal
|
May 1, 2019
Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography
Irene Hernández Lozano, Rudolf Karch, Martin Bauer, et al.
Pharmaceutics
|
August 28, 2021
Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice
Irene Hernández-Lozano, Severin Mairinger, Alexander Traxl, et al.
European Journal of Clinical Pharmacology
|
August 6, 2009
Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET
Martin Bauer, Rudolf Karch, Friederike Neumann, et al.
Theranostics
|
January 8, 2019
PET-MR and SPECT-MR multimodality probes: Development and challenges
Chang-Tong Yang, Krishna K Ghosh, Parasuraman Padmanabhan, et al.
Journal of Pharmaceutical Sciences
|
February 9, 2016
Influence of 24-Nor-Ursodeoxycholic Acid on Hepatic Disposition of [(18)F]Ciprofloxacin, a Positron Emission Tomography Study in Mice
Thomas Wanek, Emina Halilbasic, Michele Visentin, et al.
British Journal of Clinical Pharmacology
|
April 13, 2017
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[<sup>11</sup> C]verapamil in elderly vs. young subjects
Martin Bauer, Beatrix Wulkersdorfer, Rudolf Karch, et al.
Molecular Pharmacology
|
June 14, 2019
Generation and Characterization of an <i>Abcc1</i> Humanized Mouse Model (<i>hABCC1<sup>flx/flx</sup></i> ) with Knockout Capability
Markus Krohn, Viktoria Zoufal, Severin Mairinger, et al.
Page
of 16